TLSI TriSalus Life Sciences Inc

Price (delayed)

$5

Market cap

$307.87M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.21

Enterprise value

$296.01M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 27
Highlights
The gross profit rose by 27% YoY
The revenue is up by 25% year-on-year
TriSalus Life Sciences's equity has soared by 134% YoY but it has decreased by 49% from the previous quarter
TriSalus Life Sciences's quick ratio has increased by 37% YoY but it has decreased by 10% from the previous quarter
TLSI's debt is up by 2.3% year-on-year

Key stats

What are the main financial stats of TLSI

TLSI stock price

How has the TriSalus Life Sciences stock price performed over time
Intraday
1.42%
1 week
1.42%
1 month
-5.12%
1 year
2.67%
YTD
-28.37%
QTD
9.89%

Financial performance

How have TriSalus Life Sciences's revenue and profit performed over time
Revenue
$45.08M
Gross profit
$38.67M
Operating income
-$30.51M
Net income
-$28.21M
Gross margin
85.8%
Net margin
-62.6%
TLSI's net margin is up by 28% year-on-year but it is down by 2.8% since the previous quarter
The gross profit rose by 27% YoY
The revenue is up by 25% year-on-year
TLSI's operating margin is up by 21% YoY but it is down by 8% QoQ

Price vs fundamentals

How does TLSI's price correlate with its fundamentals

Growth

What is TriSalus Life Sciences's growth rate over time

Valuation

What is TriSalus Life Sciences stock price valuation
P/E
N/A
P/B
46.88
P/S
6.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.57
TLSI's EPS is up by 8% QoQ but it is down by 2.5% YoY
TriSalus Life Sciences's equity has soared by 134% YoY but it has decreased by 49% from the previous quarter
The revenue is up by 25% year-on-year
TLSI's P/S is 25% above its 5-year quarterly average of 5.1 and 20% above its last 4 quarters average of 5.3

Efficiency

How efficient is TriSalus Life Sciences business performance
TLSI's ROS is up by 32% YoY but it is down by 3.3% QoQ
The return on invested capital is up by 24% year-on-year but it has declined by 3.7% since the previous quarter
TriSalus Life Sciences's ROA has increased by 10% from the previous quarter

Dividends

What is TLSI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TLSI.

Financial health

How did TriSalus Life Sciences financials performed over time
The company's total assets is 12% higher than its total liabilities
The company's total assets has surged by 51% YoY but it fell by 12% QoQ
TriSalus Life Sciences's quick ratio has increased by 37% YoY but it has decreased by 10% from the previous quarter
TriSalus Life Sciences's equity has soared by 134% YoY but it has decreased by 49% from the previous quarter
TriSalus Life Sciences's debt to equity has soared by 96% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.